RADEK SKODA to Poly(ADP-ribose) Polymerase Inhibitors
This is a "connection" page, showing publications RADEK SKODA has written about Poly(ADP-ribose) Polymerase Inhibitors.
Connection Strength
0.141
-
Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms. Blood. 2017 12 28; 130(26):2848-2859.
Score: 0.141
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.